Trigger-point steroid injections versus hip joint steroid injections for hip osteoarthritis
Official title: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache
Run by Beijing Tiantan Hospital · NCT07347041 · Data updated 2026-11-12
This test compares steroid injections into myofascial trigger points versus injections into the hip joint to see which reduces pain and improves function in people aged 45 and older with hip osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 1036 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | June 1, 2027 |
| Registry record updated | January 16, 2026 |
| Trial ID | NCT07347041 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45 or older with radiographic hip osteoarthritis (Kellgren–Lawrence grade 1–4), chronic hip pain for more than 3 months, at least one palpable myofascial trigger point, NRS ≥3 despite conservative treatment, and able to give informed consent.
✕Probably not a fit
Patients with corticosteroid allergy, active inflammatory rheumatic disease, recent intra-articular injection, severe organ dysfunction, long-term systemic steroid therapy, or other major exclusion criteria are unlikely to derive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, controlled study with blinded outcome assessment using a non-inferiority design to compare glucocorticoid injections at myofascial trigger points (MTrPs) versus intra-articular hip injections. Participants are randomly assigned to receive either MTrP injections or joint-cavity injections and are followed for two years. Key outcome measures include pain intensity (NRS), joint function and stiffness (WOMAC), patient-reported outcomes, and safety events. The trial tests whether the simpler MTrP injection approach can provide comparable long-term symptom relief to standard intra-articular treatment.
Why it matters
Potential benefit: If successful, this could offer a simpler, potentially safer injection option that provides similar or better long-term pain relief and improved function compared with standard intra-articular steroid injections.
How similar studies have gone: Previous domestic and international studies have reported that glucocorticoid injections at MTrPs can relieve pain in knee osteoarthritis and other chronic musculoskeletal pain conditions, but randomized long-term data specifically for hip osteoarthritis remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of hip osteoarthritis with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 1-4) confirmed by at least two orthopedic surgeons, pain specialists, or general practitioners, with physical examination confirming at least one myofascial trigger point; * Disease duration exceeding 3 months; * Age ≥ 45 years; * Numerical Rating Scale (NRS) score ≥ 3 points despite prior conservative pharmacological treatment; * Signed informed consent form. Exclusion Criteria: * History of allergy to trial medications such as corticosteroids; * Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy; * Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.; * Intra-articular injection within the past 6 months or planned joint replacement surgery; * Inability to use pain assessment scales; * Presence of local or systemic infection; * Pregnant or lactating patients.
Where it's running
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Fang Luo
- Email: 13611326978@163.com
- Phone: +86 13611326978
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Steroid injections into myofascial trigger points versus joint injections for shoulder osteoarthritis
This study will test whether steroid injections into muscle trigger points work as well as steroid injections into the shoulder joint for adults with shoulder osteoarthritis and ongoing shoulder pain.
-
Glucocorticoid injections into myofascial trigger points to treat knee osteoarthritis.
This study will test whether injecting corticosteroid into myofascial trigger points reduces pain and improves function for adults 45 and older with knee osteoarthritis.
-
Ceramic hip resurfacing vs total hip arthroplasty for hip OA
This trial tests whether ceramic hip resurfacing helps people with hip OA walk farther each day than a modern total hip replacement.
-
Dexmedetomidine during hip replacement to modulate nerves and inflammation
A randomized, placebo-controlled study tests whether intravenous dexmedetomidine given during spinal anesthesia with a PENG nerve block can help regulate the body's stress and inflammatory response and improve recovery after hip replacement.
-
vEAET-H: a virtual group emotional therapy for chronic pain patients using medical cannabis in Israel
This study tests a Hebrew, virtual, group-based emotional therapy to see if it can help reduce pain and improve emotional well-being in Israeli adults with chronic musculoskeletal pain who use medical cannabis.
-
Effects of Different Myofascial Release Techniques on Function in Chronic Neck Pain
This trial tests whether manual or self-applied myofascial release, in addition to standard therapy and exercise, can improve function and reduce pain in adults with chronic non-specific neck pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.